PA
XRAY icon

Procyon Advisors’s Dentsply Sirona XRAY Stock Holding History

Procyon Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-4,174
Closed -$205K – 362
2022
Q1 		$205K Buy
4,174
+8
+0.2% +$423 0.04% 322
2021
Q4 		$232K Sell
4,166
-3,162
-43% -$174K 0.05% 296
2021
Q3 		$425K Hold
7,328
– – 0.11% 186
2021
Q2 		$464K Hold
7,328
– – 0.13% 151
2021
Q1 		$468K Hold
7,328
– – 0.21% 122
2020
Q4 		$384K Sell
7,328
-120
-2% -$5.92K 0.19% 132
2020
Q3 		$326K Hold
7,448
– – 0.18% 130
2020
Q2 		$328K Buy
7,448
+749
+11% +$31.7K 0.17% 117
2020
Q1 		$260K Buy
6,699
+1,668
+33% +$85K 0.17% 118
2019
Q4 		$285K Buy
+5,031
New +$281K 0.17% 117

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Procyon Advisors's XRAY Position: Q2 2022 in Review

Procyon Advisors sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 4,174 shares — an estimated $205K sold.

Procyon Advisors first reported a position in XRAY in Q4 2019 and held it in 10 quarters. The position peaked at $468K in Q1 2021. 470 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Procyon Advisors reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Procyon Advisors sold 4,174 Dentsply Sirona shares in Q2 2022, an estimated $205K.
  • Procyon Advisors first reported a position in Dentsply Sirona in Q4 2019 and held it in 10 quarters.
  • Procyon Advisors's Dentsply Sirona position peaked at $468K in Q1 2021.
  • 470 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Procyon Advisors's 13F filing for Q2 2022, filed 11 Jul 2022.